| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 40K | 21 Jun 2023 | Direct | ||
| LAVA Therapeutics NV | Director | Common Shares (Right to Buy) | 33.4K | 13 Feb 2025 | Direct | ||
| Cue Biopharma, Inc. | Director | Stock Option (right to buy) | 24.4K | 02 Jan 2025 | Direct | ||
| LAVA Therapeutics NV | Director | Share Options (Right to Buy) | 0 | 13 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LVTX | LAVA Therapeutics NV | 13 Nov 2025 | 1 | $0 | 4 | Director | 17 Nov 2025, 16:30 |
| LVTX | LAVA Therapeutics NV | 13 Feb 2025 | 1 | $0 | 4 | Director | 18 Feb 2025, 20:15 |
| CUE | Cue Biopharma, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Director | 03 Jan 2025, 16:00 |
| LVTX | LAVA Therapeutics NV | 01 Jan 2025 | 0 | $0 | 3 | Director | 02 Jan 2025, 09:29 |
| CUE | Cue Biopharma, Inc. | 02 Jan 2024 | 1 | $0 | 4 | Director | 04 Jan 2024, 16:02 |
| PIRS | PIERIS PHARMACEUTICALS, INC. | 21 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 16:46 |
| CUE | Cue Biopharma, Inc. | 23 Mar 2023 | 3 | -$2.9K | 4 | Director | 27 Mar 2023, 16:05 |
| CUE | Cue Biopharma, Inc. | 03 Jan 2023 | 1 | $0 | 4 | Director | 05 Jan 2023, 15:10 |
| PIRS | PIERIS PHARMACEUTICALS, INC. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 19:03 |
| CUE | Cue Biopharma, Inc. | 03 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 19:27 |
| CUE | Cue Biopharma, Inc. | 15 Nov 2021 | 6 | -$304K | 4 | Director | 17 Nov 2021, 16:00 |
| PIRS | PIERIS PHARMACEUTICALS, INC. | 25 Jun 2021 | 1 | $0 | 4 | Director | 29 Jun 2021, 17:26 |